Comparison of Human Menopausal Gonadotropins and the Combination of Human Menopausal Gonadotropins With Clomiphene Citrate in Stimulated Intrauterine Insemination Cycles

• Status: Not yet recruiting
• Trial end date: 2023-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of study is to evaluate the results of two different protocols for ovulation induction during IUI cycles. All patients undergo IUI cycles are randomly divided in to two groups. the first group is human menopausal gonadotropins and the second group is the combination of human menopausal gonadotropins with clomiphene citrate

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bezmialem Vakif University
• Treatments: Clomiphene; Enclomiphene; Menotropins; Zuclomiphene

Criteria

Inclusion Criteria:

• 18-40 years old female

• Unexplained infertility

• Regular menstrual cycle

• Bilateral tubal patency in HSG and normal uterine cavity

• Total motile sperm count greater than 10 million/ml

Exclusion Criteria:

• History of ovarian surgery

• Uncorrected uterine pathology

• Other endocrine diseases (thyroid, prolactin, hypogonadotropic hypogonadism)

• Presence of a cyst greater than 10 mm on USG in 2-3 days of the period

• Stage 3-4 endometriosis

• TMSS < 5 million/ml on the insemination day

• Conditions where HMG and clomiphene citrate are contraindicated